Top 20 Digital Therapeutics & Consumer Health Technology Providers 2026

This report forms part of the Ranking News Healthcare Ranking series, which evaluates hospitals, medical institutions, pharmaceutical organizations, medical technology companies, diagnostics providers, laboratories, precision medicine platforms, pharmaceutical services providers, medical technology firms, and healthcare systems across global healthcare markets.

Digital therapeutics and consumer health technology providers occupy a fast-evolving segment of healthcare where software, behavioral science, connected devices, telehealth, digital coaching, AI-enabled personalization, and consumer engagement are used to prevent, manage, or treat health conditions. These firms operate across chronic disease management, mental health, sleep, musculoskeletal care, metabolic health, ADHD, women’s health, medication adherence, lifestyle change, wellness analytics, and direct-to-consumer care access.

Unlike traditional medical device manufacturers or hospital IT vendors, digital therapeutics and consumer health technology providers compete through user engagement, clinical validation, software design, behavioral adherence, regulatory strategy, payer and employer adoption, consumer trust, and ability to translate health data into sustained behavior change. Their platforms may be prescription digital therapeutics, FDA-cleared software as a medical device, employer-sponsored digital care programs, consumer subscription health platforms, or hybrid digital-clinical services.

The sector has gone through a major reset. Several early prescription digital therapeutics companies struggled with reimbursement, provider adoption, and commercial distribution, while more durable companies have shifted toward enterprise contracts, consumer subscriptions, employer benefits, integrated care programs, AI-supported personalization, and condition-specific digital care. The digital therapeutics market remains projected to grow strongly, with one 2026 market estimate placing the market at about $11.98 billion in 2026 and forecasting growth to roughly $65.31 billion by 2035.

This ranking identifies digital therapeutics and consumer health technology providers whose platforms demonstrate sustained relevance across clinical evidence, consumer adoption, payer and employer integration, regulatory maturity, chronic care impact, and long-term commercial resilience. Rather than focusing only on app downloads or startup valuations, the objective is to recognize specific license-targetable firms whose platforms are meaningful within the healthcare technology ecosystem.

Market Overview

The digital therapeutics and consumer health technology market includes several overlapping categories. The first is regulated digital therapeutics, where companies such as Click Therapeutics, Big Health, Akili, Freespira, WellDoc, DarioHealth, Sidekick Health, and Kaia Health develop software-based interventions intended to treat or manage specific conditions. Big Health’s SleepioRx and DaylightRx are FDA-cleared digital mental health treatments, while Akili’s EndeavorRx is an FDA-authorized digital therapeutic for pediatric ADHD-related attention impairment.

The second category is chronic care and condition-specific digital health. Omada Health, Hinge Health, Sword Health, Twin Health, Noom, and Welldoc focus on chronic disease, metabolic health, musculoskeletal conditions, obesity, diabetes, hypertension, and behavior change. Omada went public in 2025 after building a virtual chronic care platform around diabetes prevention, metabolic health, and GLP-1-related care support.

The third category is consumer health technology. Hims & Hers, Oura, WHOOP, Calm, Headspace, Noom, Fitbit / Google, Garmin, Withings, and similar platforms serve consumers directly through subscriptions, health insights, digital coaching, virtual care, or connected health tracking. Oura raised more than $900 million in 2025 to accelerate global expansion and health innovation, while WHOOP raised $575 million at a reported $10.1 billion valuation despite regulatory friction around blood pressure functionality.

The fourth category is digital mental health and behavioral intervention. Big Health, Headspace, Calm, Talkspace, Spring Health, Grow Therapy, and others reflect strong demand for scalable, software-enabled mental health support. Within this broader category, companies with clinically validated or regulated products are especially relevant because they bridge consumer mental wellness and formal therapeutic intervention.

The fifth category is digital companion and pharma-partnered platforms. Click Therapeutics, Sidekick Health, DarioHealth, and BrightInsight-type platforms show how digital tools can support medication adherence, patient engagement, disease management, and software-enhanced therapies. Click Therapeutics received strategic Series C investment from Dassault Systèmes and Medidata in 2025, while Sidekick Health has worked with Pfizer on digital medication management and lifestyle support across Europe.

Industry Trend — 2026

The digital therapeutics and consumer health technology industry in 2026 is shaped by five major trends: regulated software maturity, chronic care commercialization, consumer subscription resilience, AI-enabled personalization, and payer-employer proof requirements.

First, regulated digital therapeutics are becoming more selective. The early wave of prescription digital therapeutics proved that software can be cleared or authorized for medical use, but reimbursement and distribution remain difficult. The strongest regulated DTx companies now focus on defined clinical use cases, clear provider workflows, evidence generation, and payer or pharmaceutical partnerships rather than relying only on app-store adoption.

Second, chronic care remains one of the most commercially durable digital health categories. Diabetes, obesity, hypertension, musculoskeletal disease, insomnia, anxiety, ADHD, and cardiometabolic disease create large and recurring costs for employers, payers, and consumers. Platforms that can improve adherence, reduce avoidable care, support medication management, or guide behavior change are better positioned than general wellness apps.

Third, consumer subscription health platforms remain important but must show durability. Hims & Hers, Oura, WHOOP, Calm, Headspace, Noom, and Withings all depend on continued engagement, brand trust, and recurring revenue. Hims & Hers’ 2026 results illustrate both the potential and volatility of consumer health platforms, with continued revenue growth but investor concern around GLP-1 competition and profitability pressure.

Fourth, AI-enabled personalization is becoming a competitive differentiator. Digital health platforms increasingly use AI for coaching, risk identification, symptom triage, adaptive intervention, behavioral nudges, content personalization, and clinician support. However, firms must avoid overstated clinical claims, especially when wellness features approach regulated medical territory.

Fifth, buyers increasingly demand evidence. Employers, health plans, providers, and consumers are more selective after the digital health funding correction. Companies that can demonstrate engagement, clinical outcomes, cost savings, FDA clearance, payer adoption, or durable consumer retention are more likely to survive than those built only on broad wellness messaging.

Methodology — Core Eligibility Criteria

To ensure structural consistency within the category, organizations considered for this ranking were evaluated based on the following eligibility conditions:

• Operates as a digital therapeutics provider, consumer health technology company, digital care platform, behavioral health technology provider, chronic care software platform, digital therapeutic software developer, or connected consumer health platform
• Provides products or services such as prescription digital therapeutics, FDA-cleared digital treatments, chronic disease coaching, digital musculoskeletal care, metabolic health programs, consumer health tracking, mental health apps, sleep interventions, medication adherence support, or virtual consumer care
• Maintains meaningful institutional scale through regulatory clearance, payer or employer adoption, consumer subscriptions, clinical evidence, public-market presence, strategic partnerships, or large user base
• Demonstrates relevance in disease management, behavioral intervention, consumer health engagement, chronic care, mental health, preventive care, wellness analytics, or software-enabled treatment
• Represents a specific license-targetable operating organization, rather than a broad ecosystem category, trade association, informal network, academic project, or generic technology label

Pure fitness-only brands, non-healthcare lifestyle apps, preclinical software concepts, research-only digital therapeutics projects, hospital systems without standalone digital product identity, and abstract platform categories were excluded.

Methodology — Ranking Factors

Organizations included in the ranking were evaluated using a combination of qualitative and structural considerations rather than short-term valuation alone. Key factors considered include:

• Strength and maturity of digital therapeutic or consumer health platform
• Clinical evidence, regulatory clearance, or therapeutic credibility
• Consumer adoption, engagement, retention, and brand trust
• Employer, payer, provider, pharmaceutical, or direct-to-consumer distribution strength
• Relevance to high-impact categories such as chronic disease, mental health, sleep, obesity, metabolic health, ADHD, musculoskeletal care, and medication adherence
• Software design, personalization, AI capability, data infrastructure, and patient experience
• Revenue durability, commercial model resilience, and platform scalability
• Institutional stability, brand reputation, and long-term healthcare relevance

The objective of the ranking is to identify digital therapeutics and consumer health technology providers whose platforms maintain sustained relevance within the global healthcare ecosystem.

The Healthcare Ranking Top 20 Digital Therapeutics & Consumer Health Technology Providers 2026 ranking evaluates companies based on clinical relevance, digital therapeutic capability, consumer reach, behavioral engagement, chronic care impact, regulatory maturity, and long-term institutional resilience.

The ranking universe consisted of approximately 150 digital therapeutics and consumer health technology providers globally, from which 20 organizations were selected for inclusion.

Tier classifications reflect relative institutional positioning within the digital therapeutics and consumer health technology sector and do not represent clinical recommendations, procurement advice, investment recommendations, or endorsement of any specific digital therapy or consumer health product.

---

Tier I — Leading Digital Therapeutics & Consumer Health Technology Providers

Omada Health

• Headquarters: San Francisco, United States
• Founded: 2011
• Core focus: Digital chronic care, diabetes prevention, obesity, hypertension, metabolic health

Omada Health is one of the leading digital therapeutics and chronic care technology providers. The company built its platform around diabetes prevention and expanded into diabetes management, hypertension, obesity, cardiometabolic care, behavioral coaching, connected devices, and GLP-1-related support.

Omada’s strength lies in clinically oriented chronic disease management. Rather than operating only as a consumer wellness app, Omada serves employers, health plans, and members through structured programs designed to support behavior change and reduce long-term healthcare costs. This gives it a stronger institutional position than many consumer-only health apps.

The company’s 2025 IPO marked an important reopening of the digital health public market and reinforced investor interest in condition-specific digital care. Its platform is especially relevant because metabolic disease, obesity, diabetes, and hypertension remain among the largest cost drivers in healthcare.

Omada’s chronic disease focus, employer and payer distribution, public-company profile, GLP-1 care relevance, and long-term digital care infrastructure support its position as a Tier I digital therapeutics and consumer health technology provider.

Hinge Health

• Headquarters: San Francisco, United States
• Founded: 2014
• Core focus: Digital musculoskeletal care, virtual physical therapy, chronic pain, AI-supported movement health

Hinge Health is one of the most important condition-specific digital health platforms, focused on musculoskeletal care, chronic pain, virtual physical therapy, movement health, and AI-supported rehabilitation. Its platform serves employers, health plans, and members seeking alternatives to fragmented physical therapy and avoidable musculoskeletal spending.

Hinge Health’s strength lies in category focus. Musculoskeletal conditions are among the largest healthcare cost categories for employers and payers, and they often require sustained engagement, coaching, exercise adherence, and behavioral support. Hinge combines digital tools, wearable-supported movement tracking, coaching, and clinical pathways to address this problem.

The company’s public-market debut in 2025 made it one of the most visible scaled digital health companies after the sector’s funding correction. Its position is especially strong because it operates in a high-cost category with clear buyer demand and measurable engagement potential.

Hinge Health’s digital MSK leadership, employer and payer relevance, AI-enabled care model, and public-company credibility support its Tier I position.

Hims & Hers Health

• Headquarters: San Francisco, United States
• Founded: 2017
• Core focus: Consumer telehealth, digital pharmacy, sexual health, dermatology, mental health, weight management

Hims & Hers Health is one of the most commercially visible consumer health technology platforms. The company combines direct-to-consumer telehealth, digital pharmacy, recurring subscriptions, sexual health, dermatology, hair loss treatment, mental health, weight management, and preventive health services.

Hims & Hers’ strength lies in consumer healthcare distribution. It has built a recognizable brand around convenience, discretion, and direct access for categories that patients often prefer to manage privately. Its platform links online intake, clinician review, prescription fulfillment, and recurring care programs into a consumer-friendly digital health experience.

The company’s 2026 performance illustrates both the opportunity and volatility of consumer health technology. It continues to generate substantial revenue and subscriber growth, but faces pressure from GLP-1 market shifts, branded-drug competition, and profitability expectations.

Hims & Hers’ consumer reach, digital pharmacy infrastructure, subscription model, and broad direct-to-consumer health platform support its Tier I position.

Oura Health

• Headquarters: Oulu, Finland / San Francisco, United States
• Founded: 2013
• Core focus: Smart ring, sleep tracking, readiness, recovery, women’s health, consumer health analytics

Oura Health is one of the leading consumer health technology providers and the strongest platform in the smart ring category. Its wearable ring tracks sleep, readiness, activity, heart rate, temperature, stress, and women’s health-related signals, creating a high-engagement consumer health data platform.

Oura’s strength lies in form factor and longitudinal engagement. A smart ring can collect passive data with less daily friction than many wrist-based devices, making it especially effective for sleep and recovery tracking. The company has also expanded its platform toward health insights, research partnerships, women’s health, and preventive health engagement.

Oura’s 2025 funding round of more than $900 million reinforced its status as one of the most significant private consumer health technology companies. Its challenge is to maintain consumer engagement while carefully managing the boundary between wellness insights and regulated medical claims.

Oura’s smart ring leadership, strong brand, large consumer base, health analytics platform, and expansion capital support its Tier I position.

Click Therapeutics

• Headquarters: New York, United States
• Founded: 2012
• Core focus: Prescription digital therapeutics, software-enhanced drugs, CNS and behavioral health

Click Therapeutics is one of the most important remaining independent prescription digital therapeutics developers. The company develops software-based prescription medical treatments and software-enhanced drug therapies, with a focus on clinically validated digital interventions and pharmaceutical partnership models.

Click’s strength lies in its commitment to regulated and prescription-grade digital medicine. In a market where several earlier digital therapeutics companies failed commercially, Click has continued to attract strategic investment and position itself around software as a medical treatment rather than general wellness engagement.

The company’s 2025 Series C investment from Dassault Systèmes and Medidata was strategically important because it connected Click’s digital therapeutics model with clinical trial technology, patient engagement, and real-world data infrastructure.

Click Therapeutics’ prescription digital therapeutics focus, software-enhanced drug strategy, strategic partnerships, and persistence in a difficult DTx market support its Tier I position.

---

Tier II — Established Digital Therapeutics & Consumer Health Technology Providers

(Alphabetical order)

Akili Interactive

• Headquarters: Boston, United States
• Founded: 2011
• Core focus: ADHD digital therapeutics, cognitive treatment software, video game-based therapy

Akili Interactive is one of the most recognizable companies in regulated digital therapeutics. Its EndeavorRx product became known as an FDA-authorized digital therapeutic for children with ADHD-related attention impairment, using game-based software to target cognitive processes involved in attention.

Akili’s strength lies in demonstrating that interactive software can be reviewed as a medical intervention rather than merely a wellness or educational product. Its model helped expand the imagination of digital therapeutics into pediatric neurocognitive care, game-based treatment, and prescription software.

The company has faced the broader commercial challenges of the prescription digital therapeutics market, including provider adoption, reimbursement, and sustainable distribution. Nevertheless, its FDA-authorized product history and recognizable digital therapeutic platform support its position among established providers.

Big Health

• Headquarters: San Francisco / London
• Founded: 2010
• Core focus: Digital mental health treatments, insomnia, anxiety, cognitive behavioral therapy

Big Health is a leading digital therapeutics company focused on mental health, sleep, anxiety, and evidence-based behavioral interventions. Its Sleepio and Daylight platforms use software-delivered cognitive and behavioral therapy to address insomnia and anxiety.

Big Health’s strength lies in combining clinical validation with scalable mental health access. Sleep and anxiety are large, under-treated categories where access to trained clinicians can be limited. Digital treatments based on structured behavioral therapy can help scale care when integrated into provider, payer, or employer workflows.

The company has received FDA clearance for SleepioRx and raised strategic funding to accelerate adoption of FDA-cleared digital mental health treatments, including SleepioRx for insomnia and DaylightRx for anxiety.

Big Health’s mental health focus, FDA-cleared products, behavioral therapy model, and employer / payer relevance support its inclusion among established providers.

Calm

• Headquarters: San Francisco, United States
• Founded: 2012
• Core focus: Mental wellness, meditation, sleep, stress management, consumer behavioral health

Calm is one of the most recognized consumer mental wellness platforms globally. Its app provides meditation, sleep stories, relaxation content, stress management tools, breathing exercises, and mental wellness programs for consumers and employers.

Calm’s strength lies in brand recognition and consumer engagement. It helped mainstream digital mental wellness and remains one of the most familiar names in meditation and sleep-related consumer health technology. Its category is less regulated than prescription digital therapeutics, but its user reach and enterprise wellness distribution make it commercially relevant.

The company’s challenge is differentiation in a crowded mental wellness market that includes Headspace, employer mental health platforms, therapy networks, and broader digital care providers. However, Calm’s consumer brand, content library, and sleep / relaxation positioning support its inclusion among established platforms.

DarioHealth

• Headquarters: New York, United States
• Founded: 2011
• Core focus: Digital chronic care, diabetes, hypertension, musculoskeletal care, behavioral health

DarioHealth is a digital chronic care platform focused on diabetes, hypertension, weight management, musculoskeletal care, and behavioral health. Its platform combines connected devices, coaching, engagement tools, and condition-specific digital programs.

Dario’s strength lies in multi-condition chronic care. Many patients do not have a single isolated condition; diabetes, hypertension, obesity, pain, and behavioral health needs often overlap. Dario has positioned itself around integrated digital support across several related categories.

The company’s enterprise and payer-facing model gives it relevance beyond consumer device sales. It competes with Omada, Hinge, Sword, Welldoc, and other chronic care platforms, but remains a specific license-targetable firm with recognized digital therapeutics and chronic disease management identity.

Freespira

• Headquarters: Kirkland, United States
• Founded: 2013
• Core focus: Digital therapeutic for panic disorder, PTSD, respiratory feedback, behavioral health

Freespira is a specialist digital therapeutics company focused on panic disorder, post-traumatic stress disorder, and respiratory-feedback-based behavioral intervention. Its platform combines software, sensors, coaching, and structured treatment protocols to support patients with anxiety-related conditions.

Freespira’s strength lies in a specific therapeutic use case. Rather than presenting itself as a broad mental wellness app, the company focuses on clinically defined behavioral health conditions where structured home-based intervention may reduce symptoms and improve access.

The company remains smaller than broad digital health platforms, but its focused digital therapeutic model, behavioral health relevance, and sensor-supported intervention make it a meaningful established provider.

Headspace

• Headquarters: Santa Monica, United States
• Founded: 2010
• Core focus: Mental health, mindfulness, meditation, coaching, therapy, employer behavioral health

Headspace is one of the leading consumer and enterprise behavioral health technology platforms. It began as a meditation and mindfulness app and expanded into broader mental health services, including coaching, therapy, psychiatry-adjacent support, employer programs, and health plan partnerships.

Headspace’s strength lies in brand trust and behavioral engagement. Mental health is one of the most important digital health categories, and Headspace has one of the most recognizable consumer brands in mindfulness and stress management. Its enterprise offerings give it access to employer and payer channels beyond direct consumer subscriptions.

The company operates in a competitive mental health market, but its combination of content, coaching, care access, and brand recognition gives it durable relevance in consumer health technology.

Noom

• Headquarters: New York, United States
• Founded: 2008
• Core focus: Weight management, behavior change, metabolic health, obesity care

Noom is a major consumer health technology company focused on behavior-based weight management, metabolic health, coaching, nutrition, and obesity-related care. Its platform uses psychology-informed programs, digital coaching, tracking tools, and subscription models to support lifestyle change.

Noom’s strength lies in consumer behavior change. Weight management is not only a medical or pharmacological category; it requires sustained engagement, habit formation, food tracking, coaching, and long-term motivation. Noom built a strong brand around this behavioral model.

The company has expanded into medically supported weight management and obesity care, reflecting the broader market shift toward GLP-1 drugs and hybrid digital-clinical programs. Its challenge is to maintain relevance as obesity care becomes increasingly medication-driven and competitive.

Noom’s consumer reach, behavioral science positioning, weight management focus, and metabolic health relevance support its inclusion among established providers.

Sword Health

• Headquarters: Draper, United States / Porto, Portugal
• Founded: 2015
• Core focus: Digital musculoskeletal care, AI care delivery, virtual physical therapy, pain management

Sword Health is a leading digital musculoskeletal care platform focused on virtual physical therapy, chronic pain, movement health, and AI-supported care delivery. It serves employers, health plans, and members seeking scalable alternatives to traditional physical therapy and avoidable MSK spending.

Sword’s strength lies in a high-cost, high-demand clinical category. Musculoskeletal conditions are a major source of employer healthcare costs, disability, and productivity loss. Sword’s platform combines digital therapy, clinical oversight, motion tracking, and AI-enabled support to address these needs.

The company competes directly with Hinge Health and other MSK platforms, but its specialist focus, enterprise distribution, and AI-oriented care model make it one of the most important private digital care providers in the category.

Twin Health

• Headquarters: Mountain View, United States
• Founded: 2018
• Core focus: Metabolic health, diabetes reversal, digital twin technology, personalized chronic care

Twin Health is a specialist digital health platform focused on metabolic health, diabetes management, and digital twin-based chronic care. The company uses connected devices, biomarkers, coaching, and personalized recommendations to support metabolic improvement.

Twin’s strength lies in data-intensive personalization. Diabetes and metabolic disease require ongoing measurement, lifestyle adjustment, medication coordination, and patient engagement. Twin’s digital twin model is designed to create personalized feedback loops using continuous patient data.

The company is especially relevant because metabolic disease remains one of the most expensive and clinically important chronic disease categories. Its focus on diabetes reversal and metabolic optimization makes it a differentiated player among digital therapeutics and chronic care providers.

WHOOP

• Headquarters: Boston, United States
• Founded: 2012
• Core focus: Wearable health, recovery, sleep, strain, performance analytics, subscription health insights

WHOOP is a leading consumer wearable health technology provider focused on recovery, sleep, strain, heart rate variability, readiness, and performance analytics. Its platform is especially popular among athletes, high-performance consumers, and users seeking continuous feedback about recovery and physiological stress.

WHOOP’s strength lies in engagement and subscription economics. Unlike many consumer wearables built around one-time hardware sales, WHOOP has emphasized membership, data interpretation, coaching, and behavior change. Its platform sits between fitness, wellness, preventive health, and performance medicine.

The company’s reported 2025 funding round at a $10.1 billion valuation demonstrated continued investor interest in consumer wearable health, even as regulatory scrutiny around medical claims remains an important boundary. WHOOP’s strong brand, subscription model, and recovery-focused analytics support its inclusion among established providers.

---

Tier III — Specialist Digital Therapeutics & Consumer Health Technology Providers

(Alphabetical order)

Kaia Health

• Headquarters: Munich / New York
• Founded: 2016
• Core focus: Digital musculoskeletal therapy, back pain, movement coaching, computer-vision-supported care

Kaia Health is a specialist digital therapeutics provider focused on musculoskeletal conditions, especially back pain and movement-based therapy. Its platform uses digital coaching, exercise guidance, education, and computer-vision-supported motion feedback.

Kaia’s strength lies in digital MSK specialization. Back pain and musculoskeletal conditions are common, costly, and often suitable for guided digital intervention when appropriately managed. Kaia competes in a crowded but important category.

Its clinical focus, European and U.S. presence, and digital therapeutic orientation support its inclusion among specialist providers.

Lark Health

• Headquarters: Mountain View, United States
• Founded: 2011
• Core focus: AI health coaching, diabetes prevention, chronic disease management, hypertension

Lark Health is a specialist digital health platform focused on AI-powered coaching for chronic disease prevention and management. Its programs include diabetes prevention, hypertension, weight management, and related cardiometabolic health support.

Lark’s strength lies in automated coaching and scalable behavior support. Many chronic care programs require frequent engagement, but human coaching is expensive and difficult to scale. Lark’s AI-based approach aims to provide lower-friction support for large populations.

Its chronic care focus, AI coaching model, and payer / employer relevance support its Tier III inclusion.

Sidekick Health

• Headquarters: Reykjavik, Iceland / Boston, United States
• Founded: 2014
• Core focus: Digital therapeutics, medication management, multi-chronic condition support, pharma partnerships

Sidekick Health is a specialist digital therapeutics and digital care platform focused on multi-chronic condition management, medication support, lifestyle intervention, and pharma-partnered digital programs. The company has emphasized gamified engagement, patient behavior change, and scalable disease-management tools.

Sidekick’s strength lies in pharma partnership and platform flexibility. Its work with Pfizer in Europe illustrates how digital therapeutics can support medication management, adherence, and lifestyle change alongside pharmaceutical treatment.

The company’s acquisition of aidhere also expanded its regulated prescription digital therapeutics capabilities. Sidekick’s multi-condition platform, pharma relationships, and European digital health identity support its inclusion among specialist providers.

WellDoc

• Headquarters: Columbia, United States
• Founded: 2005
• Core focus: Diabetes digital therapeutics, BlueStar, chronic care software, cardiometabolic health

WellDoc is one of the earliest and most established digital therapeutics companies in diabetes care. Its BlueStar platform has received multiple FDA clearances and supports adults with type 2 diabetes and related chronic disease management needs.

WellDoc’s strength lies in regulated diabetes software. The company has repeatedly expanded its FDA-cleared platform capabilities, including insulin-related decision support features. This gives it a stronger medical-device software profile than many consumer chronic care apps.

The company remains smaller than broader chronic care platforms such as Omada, but its long history, FDA-cleared diabetes focus, and clinical software identity support its Tier III inclusion.

Withings

• Headquarters: Issy-les-Moulineaux, France
• Founded: 2008
• Core focus: Connected health devices, smart scales, blood pressure monitors, hybrid watches, consumer health data

Withings is a specialist consumer health technology company focused on connected health devices, including smart scales, blood pressure monitors, sleep tracking systems, thermometers, and hybrid health watches. Its products sit between consumer wellness and home health monitoring.

Withings’ strength lies in connected home health devices rather than pure software intervention. Weight, blood pressure, sleep, heart rate, and body composition data can support preventive health, chronic disease awareness, and patient engagement over time.

The company’s European base, device design reputation, and broad connected health portfolio make it a relevant specialist provider within consumer health technology.

---

Remarks

Digital therapeutics and consumer health technology providers continue to reshape healthcare by turning software, behavioral science, connected devices, and consumer engagement into tools for prevention, disease management, mental health support, chronic care, and personalized wellness. The category spans regulated prescription digital therapeutics, digital chronic care, consumer health subscriptions, wearable insights, virtual coaching, and pharma-partnered digital treatment platforms.

The organizations recognized in this ranking represent firms whose platforms maintain sustained relevance across digital therapeutics, chronic disease management, mental health, sleep, obesity, metabolic health, musculoskeletal care, ADHD, consumer health tracking, and behavior change. Tier classification reflects relative institutional positioning within the digital therapeutics and consumer health technology sector rather than direct clinical quality rankings.

Tier classification reflects relative clinical evidence, regulatory maturity, consumer adoption, engagement quality, payer and employer relevance, platform scalability, brand strength, and long-term resilience. The ranking does not constitute a medical recommendation, procurement recommendation, investment recommendation, or endorsement of any specific digital therapeutic, wearable device, or consumer health service.

---

Recognition

Organizations included in the Top 20 Digital Therapeutics & Consumer Health Technology Providers 2026 ranking may request information regarding authorized use of the Ranking News designation for marketing and communications purposes.

Recognized institutions may reference the designation in:

• corporate websites
• investor communications
• marketing materials
• institutional presentations
• academic and recruitment materials

Ranking inclusion is editorially determined and independent of licensing, advertising, or commercial participation. Recognition-materials licenses govern only the use of official Ranking News / Healthcare Ranking assets, approved wording, and related communications materials.

Licensing inquiries:
[email protected]